Nazih Khater

Dr. Nazih Khater

Urology, Emory University, Atlanta, Georgia, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Best Practice & Research Clinical Anaesthesiology
Verified
Journal Article
Closed access
AGAlexander Gomelsky
Alexander Gomelsky
KAKenneth Abreo
Kenneth Abreo
Nazih KhaterNazih Khater
Nazih Khater
AAAdrian Abreo
Adrian Abreo
BABakhtiar Amin
Bakhtiar Amin
Alan David KayeAlan David Kaye
Alan David Kaye

25 July 2022 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
Nazih KhaterNazih Khater
Nazih Khater
NCNicholas Joseph Comardelle
Nicholas Joseph Comardelle
NDNatalie M. Domingue
Natalie M. Domingue
WBWilfredo J. Borroto
Wilfredo J. Borroto
Elyse M. CornettElyse M. Cornett
Elyse M. Cornett
Alan David KayeAlan David Kaye
Alan David Kaye
Context: Robotic surgery is becoming the most common approach in minimally invasive urologic procedures. Robotic surgery offers less pain to patients because of smaller keyhole incisions and less tissue retraction and stretching of fascia and muscular fibers. Tailored pain regimens have also evolved and allowed patients to feel minimal to no discomfort after robotic urologic surgery, allowing in parallel better surgical outcomes. This study aims to analyze the most current pain regimens in robotic urologic surgery and to evaluate the most current pain protocols and corresponding outcomes. Evidence Acquisition: A literature review was performed of published manuscripts utilizing Pubmed and Google Scholar on pain protocols for patients undergoing robotic urologic surgery. Results: Multimodal analgesia is gaining ground in robotic urologic surgery. Regional analgesia includes four major modalities: Neuroaxial analgesia, intercostal blocks, tranvsersus abdominis plane blocks, and paravertebral blocks. Each approach has a different injection site, region of analgesia coverage, and duration of coverage depending upon local anesthesia and/or adjuvant utilized with advantages and disadvantages that make each modality unique and efficacious. Conclusions: Robotic urologic surgery has offered the advantage of smaller incisions, faster recovery, less postoperative opioid consumption, and better surgical outcomes. Neuraxial, intercostal, transversus abdominis plane, and quadratus lumborum blocks are the best and most adopted approaches which offer optimal outcomes to patients.

28 February 2023 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
KMKevin Morgan
Kevin Morgan
HPHarLee Possoit
HarLee Possoit
ZCZachary Conelly
Zachary Conelly
CFClifton F. Frilot
Clifton F. Frilot
Nazih KhaterNazih Khater
Nazih Khater
AGAlexander Gomelsky
Alexander Gomelsky

1 June 2022 in Uro
Verified
Journal Article
Open access
PDF file
AAAhmad S Abdelrazek
Ahmad S Abdelrazek
AMAhmed Mahmoud
Ahmed Mahmoud
VJVidhu Joshi
Vidhu Joshi
MHMohamed Habeeb
Mohamed Habeeb
MAMohamed Ahmed
Mohamed Ahmed
AKAyse T. Kendi
Ayse T. Kendi
Prostate cancer (PCa), which is among the most prevalent types of cancer in men, is a prominent topic in imaging research. The primary aim of PCa imaging is to acquire more accurate characterizations of the disease. More precise imaging of the local stage progression, early discovery of metastatic cancers, reliable diagnosis of oligometastatic cancer, and optimum treatment response evaluation are areas in which contemporary imaging is quickly improving and developing. Imaging techniques, such as magnetic resonance imaging (MRI) for the whole body and molecular imaging with combined positron emission tomography (PET), computed tomography (CT), and MRI, enable imaging to support and enhance treatment lines in patients with local and advanced PCa. With the availability of multiple imaging modalities for the management of PCa, we aim in this review to offer a multidisciplinary viewpoint on the appropriate function of contemporary imaging in the identification of PCa.

11 April 2022 in Canadian Urological Association Journal
Verified
Journal Article
Closed access
PDF file
ZCZachary M. Connelly
Zachary M. Connelly
HPHaley Pilet
Haley Pilet
CRCharles D. Rees
Charles D. Rees
CMColeman McFerrin
Coleman McFerrin
AAAhmad Azzawe
Ahmad Azzawe
Nazih KhaterNazih Khater
Nazih Khater
Introduction: Retained ureteral stents may constitute a technical challenge. The purpose of this study was to analyze the patient population with retained ureteral stents with regards to stent sizes to better understand if these factors could play a pivotal role in their encrustation. Methods: After institutional review board approval, we retrospectively analyzed the data of patients who underwent multimodal surgical procedures for the removal of retained ureteral stents from 2010–2018. The primary outcomes analyzed were ureteral stent length and diameter, location of stent placement, and patients’ demographics as potential etiologies for encrustation. Results: We included 30 patients with 32 encrusted ureteral stents and 37 patients with 46 forgotten non-retained ureteral stents. Indications for stenting included urolithiasis, malignancy, pregnancy, ureteral stricture, and ureteropelvic junction obstruction. Stent diameters ranged from 6 Fr. to 8.5 Fr. Stent lengths ranged from 22 to 30 cm, and multilength stents were used too. Smaller diameter stents were less likely to be retained when compared to larger diameter stents (>6 Fr.) (p=0.002). Overall stent length was not found to be significant (p=0.251); however, the difference in stent surface area differed by over 1cm (p<0.001). Patients who were uninsured were more likely to have retained stents (p=0.003). Patients who reside with longer commuting distance to the main academic medical center were more likely to have retained stents (p=0.010). Conclusions: Retained ureteral stents could be avoided. Taking into consideration ureteral anatomical variation among patients, smaller diameter stents and smaller surface area may prevent encrustation. Uninsured patients, with farther distance to seek medical care, and females are the most at risk.

26 April 2022 in Health Psychology Research
Verified
Journal Article
Closed access
PDF file
NNNazir Noor
Nazir Noor
CLCourtney LaChute
Courtney LaChute
MRMathew Root
Mathew Root
JRJasmine Rogers
Jasmine Rogers
MRMadeleine Richard
Madeleine Richard
Alan David KayeAlan David Kaye
Alan David Kaye
A migraine is a clinical diagnosis with a presentation of one or more severe unilateral or bilateral headache(s) often preceded by an aura and typically accompanied by nausea, vomiting, photophobia, and/or phonophobia. This neurological disease is often debilitating and greatly affects the quality of life of those it inflicts. In fact, a recent study conducted by the Global Burden of Disease and published in The Lancet Neurology revealed that migraines ranked second to only back pain as the most disabling disease. Triggers for migraines have ranged from female sex, low socioeconomic status, and diet to loud noises, sleep hygiene, and stress. Along with its clinical presentation, laboratory tests and imaging help rule out other potential causes of the headache and lead to a diagnosis of migraine. Migraines are typically divided into three phases: prodromal, headache, and postdrome. The pathophysiology of each phase remains under investigation, with differing theories regarding their pathways. Existing therapies are abortive therapies for acute migraines or preventative therapies. Abortive therapy consists of NSAIDs and triptans. Preventative therapies include tricyclic antidepressants, calcium channel blockers, beta-blockers, and anticonvulsants. In this review, we focus on the role of NSAIDs and the COX-2 inhibitor, celecoxib oral solution, for the abortive treatment of acute migraines.